Article Details

Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance

Retrieved on: 2022-11-16 23:59:53

Tags for this article:

Click the tags to see associated articles and topics

Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance. View article details on HISWAI: https://www.bmj.com/content/379/bmj.o2759

Excerpt

NICE said that while there was evidence suggesting molnupiravir and remdesivir were effective, the current pricing means they are not likely to be a ...

Article found on: www.bmj.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up